Ajitanuj Rattan

A versatile and enthusiastic researcher with more than 6-years of post-doctoral research experience in Immunology, autoimmunity, vaccine design and drug discovery. More than 15 years of multidisciplinary and translational research experience. Demonstrated experience of working in collaborative projects, ability to work as a team. Keen interest in translational research (Immunotherapy, vaccine design), entrepreneurship, business development and science communication.

• Rattan A, Danni Z, Kristine O, Carroll MC. CD21 Blockade on B cells and FDC impede the capacity of B cell to drive generation of auto antibody secreting B cell (ASC) in mouse model of Systemic Lupus Erythematosus (SLE). (MS in preperation).
• Rattan A, White CL, Nelson S, Eismann M, Padilla-Quirarte H, Glover MA, Dileepan T, Marathe BM, Govorkova EA, Webby RJ, Richards KA, Sant AJ (2022). Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype and Recruitment to the Lung after Influenza B Infection. Pathogens. 11(2):251. https://doi.org/10.3390/pathogens11020251
• Rattan A, Richards KA, Knowlden Zackery AG and Sant AJ (2019). Protein vaccination directs the CD4 T cell response towards shared protective epitopes that can be recalled after infection. J. Virol. 93 (20): e00947-19.
• DiPiazza AT, Fan S, Rattan A, DeDiego ML, Chaves F, Neumann G, Kawaoka Y, and Sant AJ (2019). A novel vaccine strategy to overcome poor immunogenicity of avian influenza vaccines through mobilization of memory CD4 T cells established by seasonal influenza. J. Immunol. 203(6), 1502-1508. 'All authors contributed equally (first co-authors).
• DiPiazza AT, Laniewski N, Rattan A, Topham DJ, Miller J, Sant AJ (2018). CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J. Virol. 92(13), e00377-18.
• Richards KA, DiPiazza AT, Rattan A, Knowlden ZAG, Yang H, Sant AJ (2018). Diverse Epitope Specificity, Immunodominance Hierarchy, and Functional Avidity of Effector CD4 T Cells Established During Priming Is Maintained in Lung After Influenza A Virus Infection. Front Immunol. (9), 655.
• Sant AJ, DiPiazza AT, Nayak JL, Rattan A, Richards KA. (2018). CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential. Immunol Rev. 284(1), 91-105.
• Rattan A, Pawar SD, Nawadkar R, Kulkarni N, Lal G, Mullick J, and Arvind Sahu A. (2017). Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A (H1N1) 2009 virus infection. Plos Pathogen, 16;13(3); p1-26.

• Looking for new opportunities to:
• Translate my training, knowledge, and expertise in basic science to advance the clinical and preclinical research, design therapeutic tools to tackle novel emerging viruses, cancer, and autoimmunity.
• Next step in career development together with the resource to pursue my passion for innovation and advancement of research in immunotherapy and vaccine development.